Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) ROCE %: -20.06% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings ROCE %?

Singapore Institute Of Advanced Medicine Holdings SGX:9G2 +3.45% ROCE % is -20.06% as of Mar. 2026. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Singapore Institute Of Advanced Medicine Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was -20.06%.

Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Singapore Institute Of Advanced Medicine Holdings ROCE % Related Terms

Singapore Institute Of Advanced Medicine Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings ROCE % Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
-5.84 -10.04 -14.33 -22.24 -20.44

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only 0.00 -18.37 -26.49 0.00 -20.06

Singapore Institute Of Advanced Medicine Holdings ROCE % Calculation

Singapore Institute Of Advanced Medicine Holdings's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-23.875/( ( (138.757 - 12.544) + (124.715 - 17.347) )/ 2 )
=-23.875/( (126.213+107.368)/ 2 )
=-23.875/116.7905
=-20.44 %

Singapore Institute Of Advanced Medicine Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-19.164/( ( (125.212 - 23.271) + (122.299 - 33.166) )/ 2 )
=-19.164/( ( 101.941 + 89.133 )/ 2 )
=-19.164/95.537
=-20.06 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -20.06% mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a ROCE % of -20.06% as of Mar. 2026.
Is Singapore Institute Of Advanced Medicine Holdings' ROCE % too high?
Singapore Institute Of Advanced Medicine Holdings' current ROCE % is -20.06%.
How does Singapore Institute Of Advanced Medicine Holdings' ROCE % compare to HCA and THC?
Singapore Institute Of Advanced Medicine Holdings' ROCE % of -20.06% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.61, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current ROCE % is -20.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current ROCE % of -20.06%. The current ROCE % is -20.06%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current ROCE % is -20.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.